Clinical Management in Asthmatic Patients Attended in the Influential Area of Hospital Universitario Virgen de la Victoria, Málaga

NCT04653116 | Unknown DMC

• 1 other identifier: FIM-ASP-2020-01
• Study Type: observational
• Target: 300
• Locations: 1 country
• Sites: 1

Brief Summary

This evidence raises the need to determine the assistance quality care in asthma population in the influential area of Hospital Universitario Virgen de la Victoria through the assistance quality care indicators established by GEMA guidelines. The aim of this study is to obtain clinical data that allow to assess assistance quality degree in order to find improvement opportunities to achieve a better control of asthmatic patients within this influential area.

Conditions

Asthma

Keywords

asthma

Outcome Measures

Primary Outcomes (1)

• To describe the clinical management in asthmatic

  To describe the clinical management in asthmatic patients in the influential area of Hospital Universitario Virgen de la Victoria according to the assistant quality indicators established by GEMA guidelines

  6 month

Secondary Outcomes (1)

• To describe the sociodemographic and clinical characteristics

  6 month

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The study will be performed in Hospital Virgen de la Victoria, which it's the reference hospital that usually attends the asthma population of its influential area. Only patients that meet the eligibility criteria will be included in the study, and it is planned that a total estimation of 300 patients with asthma diagnose will be included in it. The whole patients will be recruited by the site investigator and collaborators, who will conduct the subject's medical chart review. Before the patient's study inclusion, the investigator team must have been obtained the signed informed consent (appendix 3) of each patient recruited and according to ICH GCP and to local legal requirements.

You may qualify if:

• Patient with written informed consent prior to participation.
• Patient female or male ≥ 18 years of age

You may not qualify if:

• \. Patient's participation in any clinical trial during the year prior to the index date for data collection.

Sponsors & Collaborators

• Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud: lead

Study Sites (1)

H. university virgen de la victoria

Málaga, Malaga, 29010, Spain

RECRUITING

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 20, 2020
• First Posted: December 4, 2020
• Study Start: November 1, 2020
• Primary Completion: November 29, 2020
• Study Completion: June 30, 2021
• Last Updated: December 4, 2020

Record last verified: 2020-11

Locations

ES (1)